MetaCap

Endovia Health Sciences Inc. (EDVA)

NYSE: EDVAConsumer StaplesBeverages (Production/Distribution)USD

0.1436-0.0007 (-0.49%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

EDVA stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$21.94
52-week range
0.134 – 6.76
Day range
0.1436 – 0.154
Volume / Avg
262.63K / 2.56M
Beta
—

52-week range

$0.134$6.76

EDVA stock today

Shares of Endovia Health Sciences (EDVA) finished lower on Nov 20 at $0.1436, a drop of 0.49% or $0.0007 per share, versus the S&P 500's 3.70% decline. Trading was light, with 262.63K shares changing hands, about 10% of the average daily volume. At this level, EDVA sits near the bottom of its 52-week range of $0.134 to $6.76: 97.9% below the high and 7.2% above the low.

Endovia Health Sciences has posted a net loss over the last twelve months (EPS of -$21.94), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Endovia Health Sciences

Company profile

Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, United Kingdom, Australia, and Latin America. Its product includes CannEpil a pharmaceutical-grade cannabinoid formulation comprising cannabidiol and tetrahydrocannabinol isolates in an oral liquid solution.

Industry
Beverages (Production/Distribution)
CEO
Mr. Brady Cobb
Headquarters
Fort Lauderdale, FL
Employees
1
IPO year
2021

Financial highlights

Full financials

In fiscal 2025, Endovia Health Sciences generated $73,066 in revenue, down 90.9% from fiscal 2024, its first annual decline since 2024. Endovia Health Sciences reported a net loss of $25.2 million, compared with a loss of $23.8 million a year earlier. Gross margin was 23.1% (up from -15.0%) and operating margin -19415.6%.

Endovia Health Sciences annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$73.07K$801.27K$18.85M$18.09M$11.32M
Growth-90.88%-95.75%+4.22%+59.84%+391.97%
Net income$-25.23M$-23.76M$-21.00M$-21.69M$-29.05M
EPS (diluted)$-11.97$-17.68$-19.79$-0.58$-1.02

Earnings

Earnings history
Last reported (Sep/2026)
Nov 18, 2026
EPS actual vs est.
$-18.04 vs —

Endovia Health Sciences peers

Consumer Staples sector
EDVA peer companies
CompanyPrice% ChgMarket capCompare
IPSTIP Strategy Holdings Inc.1.47-9.29%$1.46Mvs EDVA
YHCLQR House Inc.1.59-12.00%$2.07Mvs EDVA
AMSSAMASS Brands Inc.0.215-4.44%$2.50Mvs EDVA
IBGInnovation Beverage Group Limited0.6625-1.13%$2.80Mvs EDVA
CCUCompania Cervecerias Unidas S.A.9.79-1.04%—vs EDVA
EPSMEpsium Enterprise Limited Class A0.5601-13.16%$7.52Mvs EDVA
WVVIWillamette Valley Vineyards Inc.1.66-4.39%$8.26Mvs EDVA
SRXHSRX Global Inc.0.80-22.33%$16.15Mvs EDVA

Indexes, lists and sector

Endovia Health Sciences stock FAQ

What is Endovia Health Sciences's stock price today?

EDVA last traded at $0.1436 as of Nov 20, 4:00 PM EST, down 0.49% on the day. Prices are delayed at least 15 minutes.

Who is Endovia Health Sciences's CEO?

Mr. Brady Cobb is the chief executive officer of Endovia Health Sciences Inc., which has about 1 employees.

What is the EDVA 52-week high?

The 52-week high for EDVA is $6.76 and the 52-week low is $0.134. The stock is currently 97.9% below its high.

Compare EDVA